eli lilly and tirzepatide Lilly's weight-loss drug reduces sleep apnea severity in late-stage trials Lilly's tirzepatide demonstrates benefits in

Rising Number of Clinical Trials Drives Asia-Pacific The APAC clinical trials market size was estimated at US$ 18.87 billion in 2025, projected to increase to US$ 20.42 billion in 2026 and reach US$ 41.33 billion by 2035, showing a healthy CAGR of 7.16% across the forecast years

Watch: Split-Dose Mechanics Step by Step A board-certified physician walks through the practical mechanics of splitting a GLP-1 dose

Its about keeping it quality

Reaching and sticking to a healthy weight can be hard, but it does come with many health benefits

The challenges associated with liposomal drug administration discuss a range of factors, including stability and the short half-life of liposomal drugs, concerns about their size and penetration, encapsulation effectiveness, skin barrier integrity, and the crucial component of patient compliance